期刊
ACTA CHROMATOGRAPHICA
卷 29, 期 4, 页码 463-468出版社
AKADEMIAI KIADO RT
DOI: 10.1556/1326.2016.00056
关键词
Supinoxin; RX-5902; LC-MS/MS; P-p68; pharmacokinetics
资金
- National Research Fund of Korea [NRF-2014M3A9A9073910]
- National Research Council of Science Technology [DRC-15-01-KRICT]
- Chungnam National University
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed for the quantification of an anticancer drug, supinoxin (RX-5902), in rat plasma. Following precipitation pretreatment using 0.1% formic acid in acetonitrile, separation was performed using a reverse phase liquid chromatography column packed with C18 (3.5 mu m, 2.1 x 50 mm) along with a mobile phase of 0.1% formic acid in distilled water and 0.1% formic acid in acetonitrile at a flow rate of 0.3 mL min(-1). Detection was achieved using MS/MS by multiple reaction monitoring via an electrospray ionization source at mass/charge transitions of m/z 442.30 -> 223.30 for supinoxin and m/z 430.08 -> 223.20 for the internal standard DGG-200064. This method demonstrated a linear standard curve (r = 0.9980) over a supinoxin concentration range of 0.0005-1 mu g mL(-1), as well as intra-and inter-assay precisions below 7.08% and 13.74%, respectively, and an accuracy of 1.15-4.50%. The matrix effect, recovery, and process efficiency were 93.63%, 99.70%, and 93.33%, respectively. Thus, a sensitive and reliable LC-MS/MS method was developed and validated for the quantification of supinoxin in rat plasma. This method was successfully applied to the evaluation of pharmacokinetic studies after single intravenous and oral administration of 1 mg kg(-1) supinoxin in rats.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据